Intended Use

EnsoSleep is intended for use in the diagnostic evaluation by a physician to assess sleep quality and aid diagnosis of sleep disorders and respiratory related sleep disorders in pediatric (13 years and older) and adult patients via automatic analysis of physiological signals from polysomnography and home sleep tests.

Technology

EnsoSleep is software that processes recorded physiological signals such as EEG, ECG, EOG, EMG, airflow, oximetry, and others from polysomnography to automatically detect and score sleep stages, arousals, leg movements, and breathing events including obstructive apnea, central apnea, and hypopnea. It supports editing by clinicians and provides a cloud-based platform with a web dashboard for review and scoring. It includes automatic recognition of cardiac events but not intended for cardiovascular diagnosis.

Performance

Clinical validation included retrospective studies using thousands of sleep study epochs scored manually by experienced technologists to serve as a consensus reference. Performance metrics such as positive, negative, and overall agreement showed that EnsoSleep's automated scoring met or exceeded predicate device performance across multiple events including sleep staging, apnea-hypopnea events, arousal, leg movements, and respiratory rate events, in both adult and pediatric populations. Statistical analyses showed substantial equivalence, and performance was robust across the intended spectrum of disease severities.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    1/6/2021

    5 months
  • 2

    FDA Approval

    6/16/2021

Other devices from EnsoData, Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.